VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. in Securities Fraud Lawsuit
VERVVerve Therapeutics(VERV) Prnewswire·2024-08-29 05:24

NEW YORK, Aug. 28, 2024 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 28, 2024 in the securities class action first filed by the Firm.So what: ...